326 related articles for article (PubMed ID: 28253987)
1. Metabolic Syndrome and the Cellular Phase of Alzheimer's Disease.
Pugazhenthi S
Prog Mol Biol Transl Sci; 2017; 146():243-258. PubMed ID: 28253987
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome exacerbates amyloid pathology in a comorbid Alzheimer's mouse model.
Tyagi A; Mirita C; Taher N; Shah I; Moeller E; Tyagi A; Chong T; Pugazhenthi S
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165849. PubMed ID: 32485218
[TBL] [Abstract][Full Text] [Related]
3. Effects of Lipotoxicity in Brain Microvascular Endothelial Cells During Sirt3 Deficiency-Potential Role in Comorbid Alzheimer's Disease.
Tyagi A; Mirita C; Shah I; Reddy PH; Pugazhenthi S
Front Aging Neurosci; 2021; 13():716616. PubMed ID: 34393764
[TBL] [Abstract][Full Text] [Related]
4. A Promising Strategy to Treat Neurodegenerative Diseases by SIRT3 Activation.
Tyagi A; Pugazhenthi S
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675125
[TBL] [Abstract][Full Text] [Related]
5. White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer's disease rat model.
Ivanova N; Liu Q; Agca C; Agca Y; Noble EG; Whitehead SN; Cechetto DF
J Neuroinflammation; 2020 Jan; 17(1):29. PubMed ID: 31964387
[TBL] [Abstract][Full Text] [Related]
6. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
7. SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease.
Lee J; Kim Y; Liu T; Hwang YJ; Hyeon SJ; Im H; Lee K; Alvarez VE; McKee AC; Um SJ; Hur M; Mook-Jung I; Kowall NW; Ryu H
Aging Cell; 2018 Feb; 17(1):. PubMed ID: 29130578
[TBL] [Abstract][Full Text] [Related]
8. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
9. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the Role of WNT Signaling in Metabolic Syndrome-Linked Alzheimer's Disease.
Ali A; Ali A; Ahmad W; Ahmad N; Khan S; Nuruddin SM; Husain I
Mol Neurobiol; 2020 Jan; 57(1):302-314. PubMed ID: 31325024
[TBL] [Abstract][Full Text] [Related]
11. Microglia-Mediated Neurovascular Unit Dysfunction in Alzheimer's Disease.
Huang W; Xia Q; Zheng F; Zhao X; Ge F; Xiao J; Liu Z; Shen Y; Ye K; Wang D; Li Y
J Alzheimers Dis; 2023; 94(s1):S335-S354. PubMed ID: 36683511
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Parodi-Rullán RM; Javadov S; Fossati S
Cells; 2021 Oct; 10(11):. PubMed ID: 34831125
[TBL] [Abstract][Full Text] [Related]
13. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
14. Sirtuins as Potential Therapeutic Targets for Mitigating Neuroinflammation Associated With Alzheimer's Disease.
Fernando KKM; Wijayasinghe YS
Front Cell Neurosci; 2021; 15():746631. PubMed ID: 34630044
[TBL] [Abstract][Full Text] [Related]
15. Targeting hypercoagulation to alleviate Alzheimer's disease progression in metabolic syndrome.
Khan S; Pati S; Singh S; Akhtar M; Khare P; Khan S; Shafi S; Najmi AK
Int J Obes (Lond); 2022 Feb; 46(2):245-254. PubMed ID: 34686782
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: Recent concepts & roles.
Ghosh P; Singh R; Ganeshpurkar A; Pokle AV; Singh RB; Singh SK; Kumar A
Neurochem Int; 2021 Dec; 151():105212. PubMed ID: 34656693
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer's disease?
Luque-Contreras D; Carvajal K; Toral-Rios D; Franco-Bocanegra D; Campos-Peña V
Oxid Med Cell Longev; 2014; 2014():497802. PubMed ID: 24683436
[TBL] [Abstract][Full Text] [Related]
18. Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?
Dong Y; Li X; Cheng J; Hou L
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696107
[TBL] [Abstract][Full Text] [Related]
19. The Neurovascular Unit Dysfunction in Alzheimer's Disease.
Soto-Rojas LO; Pacheco-Herrero M; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Villegas-Rojas MM; Harrington CR; de la Cruz F; Garcés-Ramírez L; Luna-Muñoz J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670754
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices.
Wang H; Shen Y; Chuang H; Chiu C; Ye Y; Zhao L
Curr Alzheimer Res; 2019; 16(7):659-674. PubMed ID: 31580243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
